Source link : https://www.newshealth.biz/health-news/glp-1-ras-reduce-early-onset-colorectal-cancer-risk-in-t2d/
PHILADELPHIA — The use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) is associated with a significant decrease in the risk for early-onset colorectal cancer (EO-CRC) in patients with type 2 diabetes (T2D), according to the results of a retrospective study. “This is the first large study to investigate the impact of GLP-1 RA use […]
Author : News Health
Publish date : 2024-10-29 08:48:16
Copyright for syndicated content belongs to the linked Source.
